Products classification
ABOUT US
Email:
sales@ruixibiotech.com
Tel.:
02988811435
Home > products > custom-nanocomposites> fluorescent-labeled-nanocomposites
Catalog name Description price
R-M1-8693 Liposome encapsulated IR780 Liposome-Encapsulated IR780 refers to the process of incorporating the near-infrared dye IR780 into liposomes. IR780 is a hydrophobic dye that exhibits strong absorption and fluorescence in the near-infrared region of the spectrum. Liposomes, on the other hand, are lipid-based vesicles that can entrap hydrophobic molecules within their lipid bilayers or aqueous core. price>
R-M1-8715 Rhodamine B modified gold nanoparticles,50nm Rhodamine B-gold nanoparticles(50nm)/Gold nanoparticles modified with rhodamine B/Rhodamine B (RhB)-gold nanoparticles(50nm)/Gold nanoparticles (AuNP) modified with rhodamine B can be used for fluorescence imaging, cellular tracking, biosensing, and targeted drug delivery, among other applications. price>
R-M1-8716 Rhodamine B (RhB)-gold nanoparticles(20nm) Rhodamine B-gold nanoparticles(20nm)/Gold nanoparticles modified with rhodamine B/Rhodamine B (RhB)-gold nanoparticles(20nm)/Gold nanoparticles (AuNP) modified with rhodamine B can be used for fluorescence imaging, cellular tracking, biosensing, and targeted drug delivery, among other applications. price>
R-M1-8717 Gold nanoparticles (AuNP) modified with rhodamine B,10nm Rhodamine B-gold nanoparticles(10nm)/Gold nanoparticles modified with rhodamine B/Rhodamine B (RhB)-gold nanoparticles(10nm)/Gold nanoparticles (AuNP) modified with rhodamine B can be used for fluorescence imaging, cellular tracking, biosensing, and targeted drug delivery, among other applications. price>
R-M1-8749 CY5@LNP-RVG29,100nm CY5@LNP-RVG29(CY5@Liposome nanoparticles-RVG29/Cyanine5@Liposome nanoparticles-RVG29,100nm) could be used for targeted delivery and imaging purposes in neural cells expressing the nAChR receptor. The CY5 fluorescence enables visualization and tracking of the LNPs in live cells or tissues, while the RVG29 peptide sequence facilitates cell penetration and specifically targets cells expressing the nAChR receptor. price>
R-M1-8750 Cy5@LNP,100nm Cy5@LNP,100nm/CY5@Liposome nanoparticles/Cyanine5@Liposome nanoparticles,100nm can include targeted drug delivery, cellular imaging, in vivo imaging, or diagnostic applications. The choice of liposome composition, size, and surface modifications can further enhance specific functionalities, such as targeted delivery to specific cell types or tissues. price>
R-M2-10696 BSA nanoparticles@IR780 Bovine serum albumin nanoparticles@IR780/Bovine serum albumin nanoparticle encapsulating IR780/BSA nanoparticles encapsulating IR780 is a multifunctional nano diagnostic and therapeutic agent constructed by encapsulating near-infrared photosensitive dye IR780 on bovine serum albumin as a carrier. It is mainly used for photothermal/photodynamic combined therapy and imaging research of tumors. price>
R-M2-10697 BSA nanoparticles@IR1061 BSA nanoparticles encapsulating IR1061/Bovine serum albumin nanoparticles encapsulating IR1061/Bovine serum albumin nanoparticles@IR1061 is a functional nanoparticle constructed by encapsulating near-infrared two region (NIR-II) fluorescent dye IR1061 on bovine serum albumin (BSA) as a carrier, and is a high-performance integrated diagnostic and therapeutic nanoplatform for the biomedical field.It can be used for in vivo tracking, integrated tumor diagnosis and treatment, and drug delivery carriers. price>
R-M2-10708 Liposome@Icariin and CY5.5 surface modified peptide WYRGRL,100nm Liposome loaded Icariin and CY5.5 surface modified peptide WYRGRL,100nm, is a scientific research nano drug delivery system for targeted diagnosis and treatment of cartilage/bone diseases. price>
R-M2-10838 DiI Liposome@Pemafibrate (K-877) + surface peptide targeting peg2k-PECAM-1 (CD31) DiI Liposome@Pemafibrate (K-877) + surface peptide targeting peg2k-PECAM-1 (CD31)/DiI Liposome loaded Pemafibrate(K-877) and surface peptide targeting peg2k-PECAM-1 (CD31),Drug loading 2mg is a customized scientific research formulation in the field of cardiovascular targeted drug delivery, which is a PECAM-1 (CD31) targeted pembrolizumab long circulating liposome with DiI fluorescent labeling and a drug loading of 2mg. Currently, it is only in the laboratory research stage and has no clinical products on the market. price>